The Motley Fool

2 High-Growth Weed and Gold Stocks to Buy for Capital Gains

growing dividends

Two of the biggest growth areas in terms of stocks on the TSX index at the moment are weed and gold. While weed stocks have been front and centre of some of the TSX’s biggest success stories this summer, things seem to have been quiet on the gold front. So, let’s take a look at these two growth industries and see which representative stocks are the best buys in terms of growth outlook.

Guyana Goldfields (TSX:GUY)

Guyana Goldfields is involved in investing, acquiring, exploring, developing, and operating gold mines in the area of Guyana in South America. Value investors should note that this stock is discounted by 47% of its future cash flow value at the moment. Its fundamentals look good, too: a P/E of 14 times earnings is very acceptable, while a PEG of 0.3 times growth and P/B of 1.1 times book back this up.

A 42.5% expected annual growth in earnings over the next one to three years is why this stock made the list. That’s a great outlook for a gold miner and marks this one out as a clear buy for anyone looking for precious metal exposure. A return on equity 8% last year and low debt of 12.9% of net worth add to its quality.

Guyana Goldfields had a fairly flat trend in share price until it dived in mid-July; while this probably counts it out as a momentum investor’s choice, it does bode well if you like your miners to have generally low volatility.

Cronos Group (TSX:CRON)(NASDAQ:CRON)

Cronos Group is not for the fainthearted in terms of valuation. It’s overvalued by more than four times its future cash flow value, but that’s not the worst of it. It would be nice to think that Cronos Group’s P/E ratio of 709.9 times earnings is a typo, but a PEG of 7.6 times growth and P/B of 10.2 times book confirm the wild overvaluation.

Growth investors should look at that 93.2% expected annual growth in earnings over the next one to three years, though. In terms of quality, it’s all a bit hit or miss: a return on equity 1% last year does not signal good use of shareholders’ funds, though a low level of debt at 2.4% of net worth is good to see. A gently rising trend in share price until the summer when that curve swept steeply upwards may make Cronos Group a good momentum investment pick.

Competitors Canopy Growth or Aphria may make better direct plays if you want to invest in legal marijuana, though a fund-style investment may be a better choice for the more risk averse.

The bottom line

Is Cronos Group the worst-valued stock on the TSX? While it’s certainly a contender for that dubious honour, it is not a contender for a value investor’s portfolio and remains strictly for momentum investors only at this moment in time. Stick with the gold stock listed here if you want growth but value at the same time, or check out some of its competitors.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Victoria Hetherington has no position in any of the stocks mentioned.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss an important event.

Iain Butler and the Stock Advisor Canada team only publish their new “buy alerts” twice a month, and only to an exclusively small group.

This is your chance to get in early on what could prove to be very special investment advice.

Enter your email address below to get started now, and join the other thousands of Canadians who have already signed up for their chance to get the market-beating advice from Stock Advisor Canada.